Patents
Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160)
10/2004
10/21/2004WO2004089863A1 Process for the production of 2-hydroxy-4-methylthiobutyric acid ammonium salt
10/21/2004US20040210079 selective monoamine oxidase B inhibitors; neurodegenerative diseases; Alzheimer's Disease
10/21/2004US20040210051 Inhibitors of binding between vascular cell adhesion molecules and cells expressing vla-4 integrin; antiinflammatory agents
10/21/2004US20040209956 S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine maleate form II crystalline salt
10/21/2004US20040209949 Resorcinol derivatives
10/21/2004US20040209936 Compounds that modulate PPAR activity and methods of preparation
10/21/2004US20040209305 Epoxide polymer surfaces
10/21/2004DE10323839B3 Preparation of dithiodiglycol involves reacting mercaptoethanol with (gas containing) oxygen in presence of ammonia and/or amines, using copper or manganese salt
10/20/2004EP1468989A2 Compounds and methods for the inhibition of the expression of VCAM-1
10/20/2004EP1468988A1 Process of preparing disubstituted 9-alkylidenefluorenes and derivatives thereof
10/20/2004EP1467968A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
10/20/2004EP1443045A9 Carbanilide used as pesticide
10/20/2004EP1149074B1 Acetylenic sulfonamide thiol tace inhibitors
10/20/2004CN1171872C Compounds for modulation of PPAP gamma activity
10/20/2004CN1171863C Carbamate derivatives and agricultural/horticulatrual bactericides
10/20/2004CN1171861C Halogenated amidino amino acid dervatives useful as nitric oxide synthase inhibitors
10/19/2004US6806365 N-alkanoylphenylalamine derivatives
10/19/2004US6806292 Substituted imide derivatives
10/19/2004US6806264 Arylphenyl-substituted cyclic ketoenols
10/19/2004US6806024 Oxime derivatives and the use thereof as photoinitiators
10/19/2004US6805922 Mono-, oligo-and polyalkylidenefluorenes and their use as charge transport materials
10/19/2004US6805893 3-mercapto-2-methyl-butan-1-ol stereoisomers or enantiomorphs are used to flavor foods and/or beverages
10/14/2004WO2004087644A1 Mercapto-phenyl-naphthyl-methane derivatives and preparation thereof
10/14/2004WO2004087064A2 Compounds and methods for use in treating neoplasia and cancer based upon inhibitors of isoprenylcysteine methyltransferase
10/14/2004WO2004000781A3 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
10/14/2004WO2004000762A3 Propionic acid derivatives and their use as hppars activators
10/14/2004WO2003061595A3 Antibodies against and compositions containing new amphetamine derivatives
10/14/2004US20040204599 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions
10/14/2004US20040204494 Having anticancer, anti-proliferous and anti-inflammatory effects and immunosuppressive and muscle relaxing functions
10/14/2004US20040204488 S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine maleate crystalline salt
10/14/2004US20040204485 Process of preparing esters and ethers of probucol and derivatives thereof
10/14/2004US20040204478 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
10/14/2004US20040204370 such as N-deacetyl-N-(4-fluorophenoxyacetyl)thiocolchicine; liposomes; antitumor agents; anticancer agents
10/14/2004US20040204320 used as herbicides
10/14/2004US20040202930 New electrode materials derived from polyquinonic ionic compounds and their use in electrochemical generators
10/14/2004US20040202639 Facially amphiphilic polymers as anti-infective agents
10/14/2004CA2522147A1 Compounds and methods for use in treating neoplasia and cancer based upon inhibitors of isoprenylcysteine methyltransferase
10/13/2004EP1466911A2 Preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
10/13/2004EP1466898A1 Beta-amyloid protein production/secretion inhibitors
10/13/2004EP1466891A1 Carboxylic acid derivative
10/13/2004EP1466888A1 Calcium receptor-active arylalkyl amines
10/13/2004EP1465863A1 Potassium channel modulators
10/13/2004EP1465861A1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
10/13/2004EP1465611A2 Composition, synthesis and therapeutic applications of polyamines
10/13/2004EP0999204B1 Novel compound having effect of promoting neuron differentiation
10/13/2004CN1537001A Malonyl-COA decarboxylase inhibitors useful as metabolic modulators
10/13/2004CN1535956A Substituted phenyl keto-enol pesticide and weedicide
10/13/2004CN1170813C N2 phenylamidine derivatives and fungicidal composition and use
10/12/2004US6803406 Curable compound or polymers; useful for fabrication of semiconductor packaging and electronics
10/12/2004US6803388 Treating atherosclerosis and coronary artery diseases; stereoselective; chemical intermediates
10/12/2004US6803384 Diaminopropionic acid derivatives
10/12/2004US6803040 Derivatives of tricyclic antidepressants and protein and polypeptide tricyclic antidepressant derivative conjugates and labels
10/12/2004CA2100817C Heteroacetic acid derivatives
10/07/2004WO2004043911A3 N-cycloalkylglycines as hiv protease inhibitors
10/07/2004US20040198997 Copper complexes and their use
10/07/2004US20040198982 such as (4S)-1-(3-bromophenyl)-N-cyanomethyl)-4-methyl-prolinamide; for treatment of osteoporosis
10/07/2004US20040198830 Carbamic acid compounds comprising an ether linkage as hdac inhibitors
10/07/2004US20040198824 enzyme inhibitor; anticancer agents; analgesics; vision defects
10/07/2004US20040198820 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
10/07/2004US20040198793 Chemical process and new intermediates
10/07/2004US20040198716 Cysteine protease inhimbitors
10/07/2004US20040198702 copolymerzing trifluorovinyl monomers containing alkyl phosphorus group or alkyl hydroxy group, a olefin group, a oxiran group with fluoroolefin or olefin to form fluoroelastomers
10/07/2004US20040194548 Sensitive and selective method and device for the detection of trace amounts of a substance
10/06/2004EP1464639A1 Succinic acid ester of probucol for the inhibition of the expression of VCAM-1
10/06/2004EP1463726A2 Aromatic thioether liver x-receptor modulators
10/06/2004EP1463715A1 Novel glucagon antagonists
10/06/2004EP1463714A2 Vanilloid receptor ligands and their use in treatments
10/06/2004EP1463707A2 A group of novel anti-cancer compounds with specific structure
10/06/2004EP1463495A2 Agents and methods for treatment of cancer
10/06/2004EP1169312B1 Glucokinase activators
10/06/2004EP1101755B1 Anthranilic acid derivatives
10/06/2004EP1085000B1 Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt
10/06/2004CN1535260A Perfluoroalkyl-substituted amines, acids, amino acids and thioether acids
10/06/2004CN1534016A Calcium acceptor active compound
10/06/2004CN1169788C N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
10/05/2004US6800612 Have vasodilating activity and inhibit the aggregation of the platelets; releasing no
10/05/2004US6800097 For dyeing keratin fibers; hair dyes
09/2004
09/30/2004WO2004083867A2 Modulators of g protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders
09/30/2004WO2004083258A2 Branched water-soluble polymers and their conjugates
09/30/2004US20040192908 Human and veterinary medicine; drugs, cosmetics ; prevention therapy dyslipidemia; cardiovascular disorders; antidiabetic agents; obesity; hypotensive agents; antiaging agents; anticancer agents
09/30/2004US20040192681 N-acylsulfonamide apoptosis promoters
09/30/2004US20040192680 Novel amides that activate soluble guanylate cyclase
09/30/2004CA2519230A1 Modulators of the g protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders
09/30/2004CA2519092A1 Branched water-soluble polymers and their conjugates
09/29/2004EP1461323A2 Compounds for the treatment of metabolic disorders
09/29/2004EP1461311A2 Urea derivatives as vr1-antagonists
09/29/2004EP1461038A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
09/29/2004EP1460994A2 Compounds for a controlled release of active molecules
09/29/2004EP1301477B1 Method for preparing disodium 2.2'-dithiobis(ethanesulphonate)
09/29/2004EP1129082B1 Method and novel intermediate products for producing isoxazolin-3-yl-acylbenzenes
09/29/2004EP1100483B1 Glucocorticoid-selective anti-inflammatory agents
09/29/2004EP1062201B1 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors
09/29/2004CN1533400A Probes, system and methods for drug discovery
09/29/2004CN1533270A Oral administered dosage form of GABA anolog prodrugs having reduced toxicity
09/29/2004CN1532288A Defatted garlic extract containing ajoene and its preparing method and use
09/29/2004CN1168711C Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use
09/29/2004CN1168693C Substituted phenols and thiophenols useful as antioxidant agents
09/28/2004US6797843 Process for preparing rac-bicalutamide and its intermediates
09/28/2004US6797827 Process for the preparation of alpha-amino acids by hydrolysis of hydantoins at elevated pressure and elevated temperature
09/28/2004US6797755 Stabilizers and antiozonants for elastomers
1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 272